mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.2 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |